1. Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine
   Clara Hartmanshenn et al, 2016, Journal of Pharmacokinetics and Pharmacodynamics CrossRef
2. Nursing Personnel in the Era of Personalized Healthcare in Clinical Practice
   Marios Spanakis et al, 2020, Journal of Personalized Medicine CrossRef
3. Biologic Impact of Green Synthetized Magnetic Iron Oxide Nanoparticles on Two Different Lung Tumorigenic Monolayers and a 3D Normal Bronchial Model—EpiAirwayTM Microtissue
   Elena-Alina Moacă et al, 2022, Pharmaceutics CrossRef
4. Principles and applications of pharmacometrics in drug evaluation in children
   Stéphanie Leroux et al, 2018, Therapies CrossRef
5. Modular Representation of Physiologically Based Pharmacokinetic Models: Nanoparticle Delivery to Solid Tumors in Mice as an Example
   Elena Kutumova et al, 2022, Mathematics CrossRef
6. Physiologically Based Pharmacokinetic Modelling and Simulation to Predict the Plasma Concentration Profile of Doxorubicin
   George A. Mystridis et al, 2022, Pharmaceutics CrossRef
7. Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeutics
   Ioannis S. Vizirianakis et al, 2019, Expert Review of Precision Medicine and Drug Development CrossRef
8. Application of physiologically based pharmacokinetics modeling in the research of small-molecule targeted anti-cancer drugs
   Xiaowen Wang et al, 2023, Cancer Chemotherapy and Pharmacology CrossRef
9. Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling
   Panagiotis Zagaliotis et al, 2022, International Journal of Molecular Sciences CrossRef
10. Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis Tools
    Elena O. Kutumova et al, 2022, International Journal of Molecular Sciences CrossRef
11. In Silico Pharmacology for Evidence-Based and Precision Medicine
    Marios Spanakis, 2023, Pharmaceutics CrossRef
12. Pharmacological Development of Target-Specific Delocalized Lipophilic Cation-Functionalized Carboranes for Cancer Therapy
    Eirini D. Tseligka et al, 2016, Pharmaceutical Research CrossRef
13. Dynamical systems approaches to personalized medicine
    Jacob D Davis et al, 2019, Current Opinion in Biotechnology CrossRef
14. Towards Treatment Patterns Validation in Lung Cancer Patients
    Arturo Redondo et al, 2021, 2021 IEEE 8th International Conference on Data Science and Advanced Analytics (DSAA) CrossRef
15. Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape
    Androulla N. Miliotou et al, 2023, Current Issues in Molecular Biology CrossRef
16. Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model
    Shun Asami et al, 2017, BMC Systems Biology CrossRef
17. Engineered Nanoparticles: Are They an Inestimable Achievement or a Health and Environmental Concern?
    Sein León-Silva et al, 2018, Agricultural Nanobiotechnology CrossRef
18. Toxicokinetics, pharmacokinetics, and absorption, distribution, metabolism, and excretion
    Anshul Gupta, 2020, Information Resources in Toxicology CrossRef
19. Precision nanomedicine in cancer: how far are we from personalization?
    Pedro Viana Baptista, 2016, Expert Review of Precision Medicine and Drug Development CrossRef
20. The Role of in silico Research in Developing Nanoparticle-Based Therapeutics
    Migara Kavishka Jayasinghe et al, 2022, Frontiers in Digital Health CrossRef
21. Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms
    Chaozhuang Shen et al, 2024, Pharmaceutical Research CrossRef